CYP 2.08% 23.5¢ cynata therapeutics limited

Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial, page-161

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,020 Posts.
    lightbulb Created with Sketch. 781
    blokes: "And if they got a CEO with some heft and ability to bring investors along for the ride it doubles in a month."

    blokes/others: Most holders of CYP (i.e. the ones a bit longer than just the last few months...) are FULLY aware that what is holding this company back is mainly (or ONLY?!) the poor management of CYP. IF that is only due to the CEO or the overall management team I am not quite sure.
    What is (or will be), however, (again JIMHO) necessary will be a CHANGE in management to make this company successful. WHEN will that finally happen?? Until then, I do not foresee a really great future for CYP holders - in spite of CYP holding extremely valuable technology.
    BUT: Best technology poorly managed will still not amount to much - sadly!

    All the aforementioned comments purely JIMHO as always. I do wish for a better situation for holders and buyers of CYP!

    wasa

    PS: I shall continue to HOLD and do HOPE for a change in management one of these days.


 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.